Sigma Foods (SIGMAF) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
31 Oct, 2026Executive summary
2023 revenue fell 9% YoY as Alpek’s decline outweighed food-segment growth; reported and comparable EBITDA fell 33% and 20%, respectively.
Transformation advanced through the Axtel spin-off, lower shareholder distributions, debt refinancing and cost actions; priorities include asset monetization, debt reduction and a potential Alpek spin-off.
Financial highlights
2023 revenue was $16.388B, down 9% YoY; 4Q23 revenue was $3.885B, down 13% YoY, mainly on lower Alpek volume and prices.
2023 reported EBITDA was $1.391B, down 33% YoY; comparable EBITDA was $1.623B, down 20% YoY.
4Q23 reported EBITDA was $282M, down 19% YoY; comparable EBITDA was $395M, down 8% YoY.
FY operating income was $149M versus $1.608B in 2022; 2023 included $756M of impairments.
4Q23 majority net loss was $652M; FY majority net loss was $711M versus net income of $578M in 2022.
Outlook and guidance
2024 priorities include selective asset monetization, debt reduction and completion of the transformation, including a potential Alpek spin-off, conditional on a solid financial position for the combined entity.
Food-business outlook is steady, with strong Americas performance expected and gradual improvement in Europe.
Petrochemical recovery is expected to remain slow amid persistent market headwinds; reference margins showed initial improvement late in 2023.
Alpek’s cost and cash actions included two plant closures with more than $40M in expected annual savings; capex was optimized against initial guidance.
Latest events from Sigma Foods
- Record results lifted FY26 Comparable EBITDA guidance to $1.14B.SIGMAF
Q3 2026 - Global packaged food leader with robust growth, profitability, and strong sustainability focus.SIGMAF
Corporate presentation - Record 2Q revenue and EBITDA growth, with strong outlook and disciplined capital allocation.SIGMAF
Q2 2026 - Record revenue and EBITDA growth driven by brand strength, efficiency, and innovation.SIGMAF
Corporate presentation - Record Q1 volume, revenue, and EBITDA growth, with 2026 guidance reaffirmed.SIGMAF
Q1 2026 - Record revenues, margin expansion, Alpek spin-off, and strong 2026 outlook with increased dividends.SIGMAF
Q4 2025 - Sigma posts record EBITDA and sales as ALFA advances Alpek spin-off and reduces leverage.SIGMAF
Q3 2024 - 2Q24 EBITDA up 23% year-over-year; 2024 guidance raised on Sigma's strong results.SIGMAF
Q2 2024 - Transformation complete; Q1 2025 EBITDA $220M, on track for $1B annual target despite FX and cost pressures.SIGMAF
Q1 2025